Concepedia

Peer-Reviewed Publication of Clinical Trials Completed for Pediatric Exclusivity

Daniel K. Benjamin, Philip Brian Smith, M. Dianne Murphy, Rosemary Roberts, Lisa L. Mathis, Debbie Avant, Robert M. Califf, Jennifer S. Li

JAMA · 2006 · 144 citations · 29 references

DOIFull text

Open access

Abstract

The pediatric exclusivity program has been successful in encouraging drug studies in children. However, the dissemination of these results in the peer-reviewed literature is limited. Mechanisms to more widely disperse this information through publication warrant further evaluation.

References

29

Publication bias in clinical research

Philippa Easterbrook, Radha Gopalan, Jesse A. Berlin et al. · The Lancet · 1991 · 3.1K citations · Full text

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

David Michelson, Douglas E. Faries, Joachim Wernicke et al. · PEDIATRICS · 2001 · 668 citations

Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials

John P. A. Ioannidis · JAMA · 1998 · 630 citations

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

David Michelson, Albert J. Allen, Joan Busner et al. · American Journal of Psychiatry · 2002 · 598 citations

Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

Graham J. Emslie, John H. Heiligenstein, Karen Dineen Wagner et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2002 · 574 citations

, , +12